Schrödinger

Schrödinger

Software Development

New York, New York 47,688 followers

Transforming drug discovery and materials research

About us

Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com.

Industry
Software Development
Company size
501-1,000 employees
Headquarters
New York, New York
Type
Public Company
Founded
1990

Locations

  • Primary

    1540 Broadway

    24th Floor

    New York, New York 10036, US

    Get directions
  • 1 Main St

    11th Floor

    Cambridge, Massachusetts 02142, US

    Get directions
  • 101 SW Main St

    Portland, Oregon 97204, US

    Get directions
  • 9868 Scranton Road

    Suite 3200

    San Diego, California 92121, US

    Get directions
  • Q7, 23

    Mannheim, Baden-Württemberg 68161, DE

    Get directions
  • No. 147, 3rd Floor Jawaharlal Nehru Main Road Channasandra 5th Stage Rajarajeshwari Nagar Above State Bank of India

    Bangalore, Mahalakshmipuram 560 086 , IN

    Get directions
  • 17F Marunouchi Trust Tower North 1-8-1 Marunouchi

    Tokyo, Chiyoda-ku 100-0005, JP

    Get directions
  • 12 Michigan Drive

    Natick, Massachusetts 01760, US

    Get directions

Employees at Schrödinger

Updates

  • View organization page for Schrödinger, graphic

    47,688 followers

    Schrödinger was thrilled to host a lunch and learn at our NYC headquarters for local life science executives, as part of our partnership with Life Science Cares. Many thanks to all who joined us for this inspiring event!

    View organization page for Life Science Cares New York, graphic

    1,285 followers

    Last week, Life Science Cares New York Board Members had the incredible opportunity to dive into Schrödinger's innovative platform and programs. Schrödinger is pushing the boundaries of computational chemistry, molecular modeling, and drug discovery and materials design. From their state-of-the-art platform that helps scientists model complex molecular structures to the impact they’re making on drug discovery programs, we left inspired by their contributions to the field. Thank you to the Schrödinger team Alex Schuman, MBA, Sasha Varasano, Geoffrey P., Robert Abel, Wu Yin, and Jennifer Chambers for hosting such a dynamic session, and to everyone who joined us! #LifeSciences #DrugDiscovery #Innovation #LunchAndLearn #ComputationalChemistry #Schrödinger #LifeScienceCaresNY

    • No alternative text description for this image
  • View organization page for Schrödinger, graphic

    47,688 followers

    At Emory University, implementing a unified Schrödinger site license has democratized access to cutting-edge computational tools across the institution, empowering more than 3,000 individuals in research positions to leverage Schrödinger’s platform. Read our latest Extrapolations blog to learn how shifting from a closed, piecemeal system to fully open, campus-wide access has elevated the research landscape at Emory: https://hubs.li/Q02SD0Kw0

    • No alternative text description for this image
  • View organization page for Schrödinger, graphic

    47,688 followers

    Schrödinger today announced that new preclinical data on SGR-3515, our investigational Wee1/Myt1 inhibitor, and our PRMT5-MTA inhibitor program, will be presented during poster sessions at the 36th EORTC-NCI-AACR Symposium (ENA 2024) taking place October 23-25, 2024 in Barcelona, Spain. Read our press release to learn more: https://lnkd.in/eB7JpfG3

    • No alternative text description for this image
  • View organization page for Schrödinger, graphic

    47,688 followers

    Join us for the last three webinars of our Computationally-Guided Drug Formulation Webinar Series – in which we explore how the latest computational modeling tools are impacting the various steps in the pharmaceutical formulation process. • October 9 | Molecular-level insight into solubility-enhancement via cosolvents and amorphous solid dispersions • October 23 | Crystal structure prediction workflow for small molecule drug formulation • November 6 | Modeling lipid nanoparticles: Self-assembly and apparent pKa calculation Register here: https://hubs.li/Q02SFGcT0

    • No alternative text description for this image
  • View organization page for Schrödinger, graphic

    47,688 followers

    It was a pleasure to host students from the Harvard Medical School Therapeutics Graduate Program at Schrödinger's Cambridge office last week. Schrödinger team members presented an overview of how our computational platform is deployed to accelerate collaborative and internal drug discovery projects, giving students a better understanding of real-world industry challenges. We are grateful for the opportunity to help prepare the next generation of scientists through in-person engagement and educational resources. Learn more about our online certification courses: https://lnkd.in/eCUuXUdM Explore our Teaching with Schrödinger initiative: https://lnkd.in/e9budee4

    • No alternative text description for this image
  • View organization page for Schrödinger, graphic

    47,688 followers

    Schrödinger is excited to be participating in the AAPS 2024 PharmSci 360 conference taking place on October 20th – 23rd in Salt Lake City, Utah. Stop by our booth #2503 to learn how molecular modeling can enhance your formulations research, and join us for two presentations by Schrödinger scientists: • Monday, October 21, 10:00 – 10:30 AM MDT: "Coarse-grained modeling of nucleic acid-loaded lipid nanoparticle formulations" presented by Doug Grzetic, Senior Scientist I • Monday, October 21, 3:15 – 3:30 PM MDT: "Modernize your arsenal of formulation tools with physics-based molecular simulation" presented by Ben Coscia, Principal Scientist I Learn more: https://lnkd.in/eB9nTwji

  • View organization page for Schrödinger, graphic

    47,688 followers

    Are you attending this year’s SEPAWA Congress in Berlin, Germany? Join our talk by Schrödinger's Jeffrey Sanders to learn how active learning technology, which incorporates physics-based simulation and experimental data in ML models, can help advance cosmetics R&D. Visit our booths 832 & 833 for demos, discussions, and inspiration. Learn more: https://hubs.li/Q02R8lHn0 #Schrodinger #MaterialsScience #Sustainability #Cosmetics

    • No alternative text description for this image
  • View organization page for Schrödinger, graphic

    47,688 followers

    Schrödinger will be at this year’s Festival of Biologics on October 15-17th in Basel, Switzerland. Don't miss the presentation by Esam Abualrous, Advances in Structure-Based Computational Modeling and Collaborative Enterprise Informatics for Biologics. Stop by our booth 640 to speak with Schrödinger scientists and discover how computational modeling can accelerate your biologics discovery. Learn more: https://hubs.li/Q02R3P810

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs

Funding

Schrödinger 10 total rounds

Last Round

Grant

US$ 10.0M

See more info on crunchbase